Zoan Biomed are delighted to announce Derek Cawley as an advisor to the company as they continue to strengthen the team. Derek works as a spine surgeon in Dublin, Ireland (www.thespineacademy.ie). He completed spine fellowships at CHU Bordeaux, France and RNOH Stanmore, UK. Awards include the BOA ZimmerTrauma, Eurospine, Ethicon, Mark Paterson and EFORT travelling fellowships. Derek chairs the PatientLine group as part of the European Spine Society and is the editor of the popular patient website www.myorthoclinic.com. Previously Derek completed Masters’ degrees in Medical Sciences and in Surgery.He directs the Spinal Studies Module on the UCD Masters in Physiotherapy. Derek has co-authored over 70 research papers, 4 book chapters and a book entitled “Spinal Anatomy: Modern Concepts”.
Thank you to the Cellink team for hosting us in their highly impressive facility in Gothenberg.
We are making excellent progress towards our development of 3D bioprinted tissue model containing sustainably grown coral skeletal particles.
Zoan and partners at TERMIS 2023
Zoan, Cellink and University of Galway collaboration on 3D printable coral-containing bioinks to present results at TERMIS, Manchester, 28-31st March 2023: Biocompatibility of 3D bioprinted tissue model prototypes containing sustainably grown coral skeletal particles for orthopedic applicationsE. Pernevik et. al. Zoan and partners at CELLINK and University of Galway will be presenting the early results from our coral bioink…
Our Sustainability Model
As a Med Tech company that aims to improve people’s health, we recognise the need to preserve a healthy environment. The link between human and environmental health is well established: the WHO states that one in four premature deaths is related to environmental issues caused by humans and the World Bank acknowledges that sustainable management…
Novel Collaboration between Zoan Biomed and University of Galway to Assess Laboratory Bone Formation
Zoan Biomed and the University of Galway to develop high throughput rapid assessment methods for biocompatibility and osteogenic potential of orthopaedic scaffold; reducing time to clinical data and developing a path to remove the need for animal testing.
To find out more about Zoan BioMed get in touch